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Dublin & DCU Location 
National Centre for Sensor Research (NCSR) 
•  Over 220 f/t researchers and support staff 
•  23 affiliated faculty 
•  Research investments and income since 
1999 now >€100 million 
•  1500 m2 well-equipped specialist lab space 
and offices 
•  Phase II expansion completed  2008 (1300 
m2) 
•  NCSR is a ‘Hosting Centre’ – supports 
externally funded initiatives 
Beaufort, SmartCoast, SmartBay, Strive 
 
The Centre for Sensor Web Technologies 
4	  
Insight Centre for Data Analytics 
•  Biggest single research investment ever by Science Foundation  
•  Biggest coordinated research programme in the history of the state 
•  Focus is on ‘big data’ related to health informatics and pHealth 
What is a Chemo/Bio-Sensor? 
‘a device, consisting of a transducer and a chemo/bio-sensitive 
film/membrane, that generates a signal related to the 
concentration of  particular target analyte in a given sample’ 
Signal out Transducer surface 
Conducting cable/track 
Chemo/bio-sensitive 
film 
Chemo/Bio-sensing involves selective BINDING & TRANSDUCTION on the 
device surface; this also implies the target analyte MUST meet the device 
surface (LOCATION & MOVEMENT). It provides a signal observable in the 
macroscopic world (COMMUNICATION) 
History: Calixarenes, 1984/5 
Tetraphosphine oxide - Ca2+ selective Tetraester - Na+ selective 
+ è 
PVC - Membrane ISEs 
Typical membrane cocktail (%w/w); PVC:33%, NPOE 
(plasticiser):66%; ionophore/exchanger: 1% (ratio at least 2:1 by 
mole); dissolve in a volatile solvent e.g. THF and cast 
membrane from this solution 
 
Blood Analysis; In-Vivo Sensing 
Anal. Chem., 64 (1992) 1721-1728.	

Ligand (and variations of) used in many 
clinical analysers for blood Na+ profiling 
1985: Catheter Electrodes for 
intensive care – function for 24 hr 
 
Dr. David Band, St Thomas’s 
Hospital London 
Control of membrane interfacial 
exchange & binding processes 
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Remote, autonomous chemical sensing is a tricky business! 
Implantable sensors e.g. The 
Artificial Pancreas…. 
•  Implantable unit comprising a glucose sensor (based 
on enzyme glucose oxidase) coupled with insulin 
reservoir 
•  Effective lifetime – many years (5-yr minimum target) 
•  Problem: glucose biosensor will not function reliably 
for more than a few days when implanted 
•  How to remotely calibrate 
•  Stability of reagents/calibrants 
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But the concept of the artificial pancreas has been around for decades; 
SUGAR ELECTRODE SENSOR FOR ARTIFICIAL PANCREAS 
By: BESSMAN, SP; SCHULTZ, RD 
HORMONE AND METABOLIC RESEARCH  Volume: 4   Issue: 6   Pages: 
413-417   Published: 1972 
Artificial Pancreas 
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Sugar levels: sub-cutaneous 
insulin 
Sugar levels: 
artificial pancreas 
Insulin addition 
A M Albisser, B S Leibel, T G Ewart, Z Davidovac, C K Botz, W Zingg, H Schipper, and R Gander 
Clinical Control of Diabetes by the Artificial Pancreas 
Diabetes May 1974 23:5 397-404; doi:10.2337/diab.23.5.397 1939-327X    (Toronto) 
Used a Technicon segmented 
flow  colorimetric glucose 
analyser 
Impantable Artificial Pancreas 
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An implantable artificial pancreas, W. 
Schubert, P. Baurschmidt, J. Nagel, R. 
Thull, M. Schaldach; 
 
Medical and Biological Engineering and 
Computing, July 1980, Volume 18, Issue 
4, pp 527-537 
‘Intravascular blood glucose sensing is difficult owing to the complex 
technology involved and the foreign body reaction of blood.’ 
‘The measurement of glucose in tissue would be easier to handle, but it 
has not been established whether the extravascular tissue 
concentration of glucose is sufficiently significant to serve as an 
input signal for a closed-loop system’ 
Adam Heller 
•  Abbott Press Release  
September 29, 2008 
•  Abbott Park, Illinois — Adam Heller, 
Ph.D., a professor at the University of 
Texas in Austin who created the 
technology that led to the development 
of Abbott's FreeStyle Blood Glucose 
Monitoring Systems® and FreeStyle 
Navigator® Continuous Glucose 
Monitoring System, today received the 
2007 National Medal of Technology 
and Innovation from President George 
W. Bush in an award ceremony at the 
White House. 
San Francisco Business Times; Tuesday, 
April 6, 2004 
 
‘Abbott completes TheraSense acquisition’ 
 
Abbott Laboratories said Tuesday it 
completed its $1.2 billion acquisition of 
Alameda-based TheraSense Inc. after a 
majority of shareholders approved the 
transaction a day earlier. 
Subcutaneous sampling of interstitial fluid 
using microneedles to access the fluid 
through the skin without causing bleeding 
Freestyle 
Navigator 
•  Combines microfluidics with 
a micro-dimensioned 
filament sampling unit which 
is designed to minimise 
incidence of infection 
(therefore can be left in place 
for 5 days). 
•  Measures glucose in 
interstitial fluid (not blood).  
Diabetics have poor 
peripheral blood supply; 
therefore this is a major 
advance. 
•  Wireless communications 
used to harvest data 
continuously, and relay to 
carers and specialists.  
Enables trending, 
aggregation, warning…. 
Target is for several days (up to 7) 
continuous monitoring; then replace; 
 
Freestyle Navigator appears to have been 
withdrawn from the US market (2012); 
 
Reasons unclear but likely to be related to 
biofouling of the electrodes or other issues 
related to the electrochemical measurement;  
 
Biocompatibility is still a huge issue! 
So where are we? 
•  The dominant model for success (outside 
specialised laboratories) in clinical applications for 
chemical sensors and biosensors is primarily based 
on ‘single shot’ or at best short-term use (hours, 
days), employing disposable devices. 
•  Long-term chemo/bio-sensor implants are still a long 
way off. 
–  Fundamental breakthroughs are required to make progress 
•  In the meantime, on-body sensing (non- or 
minimally-invasive….. ) offer opportunities. 
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What sample do we go for? 
blood, sweat, tears……….. 
The technology is happening…
Jawbone 
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Jawbone UP24 
Moves & Facebook – Leveraging 
embedded mobile phone sensors 
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April 2014: INTEL acquires BASIS 
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Nike & Apple 
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Apple iWatch 
20	  
Apple, iWatch & Health Monitoring 
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‘Over the past year, Apple has snapped up at 
least half a dozen prominent experts in 
biomedicine, according to LinkedIn profile changes.  
 
Much of the hiring is in sensor technology, an 
area Chief Executive Tim Cook singled out last 
year as primed "to explode."  
 
Industry insiders say the moves telegraph a vision of 
monitoring everything from blood-sugar levels 
to nutrition, beyond the fitness-oriented devices 
now on the market.’ 
 
"This is a very specific play in the bio-sensing 
space," said Malay Gandhi, chief strategy officer at 
Rock Health, a San Francisco venture capital firm 
that has backed prominent wearable-tech startups, 
such as Augmedix and Spire.  
May 7th 2014 
Google Contact Lens 
United States Patent Application  20140107445   
Kind Code  A1  Liu; Zenghe  April 17, 2014   
Microelectrodes In An Ophthalmic Electrochemical 
Sensor  
Abstract 
An eye-mountable device includes an electrochemical 
sensor embedded in a polymeric material configured for 
mounting to a surface of an eye. The electrochemical 
sensor includes a working electrode, a reference 
electrode, and a reagent that selectively reacts with an 
analyte to generate a sensor measurement related to a 
concentration of the analyte in a fluid to which the eye-
mountable device is exposed. The working electrode can 
have at least one dimension less than 25 micrometers. The 
reference electrode can have an area at least five times 
greater than an area of the working electrode. A portion of 
the polymeric material can surround the working electrode 
and the reference electrode such that an electrical current 
conveyed between the working electrode and the reference 
electrode is passed through the at least partially surrounding 
portion of the transparent polymeric material. 
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http://www.gmanetwork.com/news/story/360331/scitech/technology/google-
s-smart-contact-lenses-may-arrive-sooner-than-you-think 
Glucose Sensor in a contact lens 
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A contact lens with embedded 
sensor for monitoring tear glucose 
level, H. F. Yao, A. J. Shum, M. 
Cowan, I. Lahdesmaki and B. A. 
Parviz, Biosensors & 
Bioelectronics, 2011, 26, 3290-3296. 
Babak Parviz et al. 
Babak Parviz: LED implanted on a 
contact lens 
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http://www.extremetech.com/extreme/174979-the-next-step-in-googles-cyborg-
plans-smart-contact-lenses-for-those-with-diabetes  
“There’s basically just two components, sandwiched between 
two layers of contact lens material: An antenna and rectifier, and 
a small glucose sensor. The problem with smart contact lenses, 
though, is the power source.”  
“The team, led by Babak Parviz, (University of Washington -> 
Google) has successfully displayed a single, remotely-controlled 
pixel onto a contact lens worn by a rabbit. Power from an 
external battery is transmitted via RF to an antenna that runs 
around the edge of the contact lens (the gold ring that you see in 
the image below), so that the wearer’s vision isn’t obstructed.” 
These comments don’t mention the issues associated with in-situ biosensing; the real problem will lie 
in the reliability of the biosensor over the period of typical use.   
Perhaps there’s a chance, as contact lenses are typically replaced on a daily basis. 
Latest	  Trends	  –	  Ta6oo	  format	  sensors	  
Prof. John Rogers @ 
University of Illinois 
Next Generation: Watch Fluidic 
Sensor Concept 
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Smart Gumshield 
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Wearable	  Cameras	  
•  Large	  marketspace	  potenBal	  
–  The	  market	  for	  Google	  Glass	  hardware	  alone	  is	  es6mated	  to	  be	  worth	  
$11B	  by	  2018	  
–  Global	  market	  for	  wearables	  in	  health	  and	  ﬁtness	  could	  reach	  170	  million	  
devices	  by	  2017,	  an	  annual	  growth	  of	  41%	  (AIB	  research)	  
ACS Breakthrough Science Videos 
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Immunochromatographic Diagnostic Test Analysis Using Google Glass  
Steve Feng, Romain Caire, Bingen Cortazar, Mehmet Turan, Andrew Wong, and Aydogan Ozcan  
DOI: 10.1021/nn500614k 
Using Google Glass for Diagnostics 
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ACS Nano 8 (3) 3069-3079, 2014   
Conclusions 
•  Invasive/implantable chem/bio-sensors that function 
for 5 or more years (target for pancreas) are still well 
beyond the state-of-the-art 
•  Real-time in-situ Chem/Bio monitoring for days is 
possible 
•  Use model that involves regular changing of the 
sensor is the key to success with current 
technologies 
•  Breakthroughs will emerge from multi-partner 
collaborations across industry and academia 
•  Arrays of short-term use sensors are possible, 
provided low cost liquid handling approaches can be 
realised 
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